Maravai LifeSciences reduces board from 11 to 8; three directors resign

MARAVAI LIFESCIENCES HOLDINGS, INC.

Benjamin Daverman, Jessica Hopfield, and Murali Prahalad resigned from the Board effective Oct 21, 2025.
Board size reduced from 11 to 8 directors effective Oct 27, 2025; resignations were not due to any disagreement.
R. Andrew Eckert named chair of Nominating, Governance and Risk Committee and member of Audit Committee.
Gregory T. Lucier appointed to Nominating, Governance and Risk Committee; unvested RSUs for departing directors accelerated.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.